Table 3. Summary of Clinical Data from Published Case Reports of HBV Reverse Seroconversiona.
Pre-treatment | Post-treatment | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Authors | Age | Sex | Diagnosis | HBsAg | anti HBs | anti HBc | HBV DNA | Intervention | Time to Reactivation | HBsAg | anti HBs | anti HBc | HBV DNA | Outcome |
Wands et al.52 | 21 | M | AML | Neg | Pos | Not done | Not done | Cytotoxic chemo | 2 mos | Pos | Neg | Not done | Not done | Serologic resolution |
Chen et al.55 | 35 | F | SAA | Neg | Pos | Pos | Not done | Bone Marrow Transp | 12 mos | Pos | Neg | Pos | Not done | Active/N.S.b |
Lok35 | N.S. | M | NHL | Neg | Pos | Pos | Negative | Cytotoxic chemoc | N/A | Pos | Neg | N.S.b | Detected | Carrier state |
Dhedin et al.56 | 38 | M | CML | Neg | Pos | Not done | Not done | Bone Marrow Transp | 12 mos | Pos | Neg | pos | Detected | Serologic resolution |
Dhedin et al.56 | 44 | M | AML | Neg | Pos | Pos | Not done | Bone Marrow Transp | 10 mos | Pos | Neg | pos | Detected | Hepatitis/N.S. b |
Dhedin et al.56 | 44 | M | SAA | Neg | Pos | Pos | Not done | Bone Marrow Transp | 6 mos | Pos | Neg | pos | Detected | Serologic resolution |
Dhedin et al.56 | 46 | M | ALL | Neg | Pos | Pos | Not done | Bone Marrow Transp | 18 mos | Pos | Neg | pos | Detected | Serologic resolution |
Goyama60 | 59 | M | Acute Leukemia | Neg | Pos | Pos | Not done | Bone Marrow Transp | 6 mos | Pos | Neg | Neg | Detected | Serologic resolution |
Goyama60 | 52 | M | CML | Neg | Pos | Pos | Negative | Bone Marrow Transp | 11 mos | Pos | Neg | Pos | Detected | Serologic resolution |
Knoll et al.59 | 41 | M | ALL | Neg | Pos | Pos | Detected | Bone Marrow Transp | 14 mos | Pos | Neg | pos | Detected | Serologic resolution |
Knoll et al.59 | 55 | M | CML | Neg | Pos | Pos | Not done | Bone Marrow Transp | 22 mos | Pos | Neg | pos | Detected | Carrier state |
Knoll et al.59 | 51 | M | CML | Neg | Pos | Not done | Detected | Bone Marrow Transp | 12 mos | Pos | Neg | Not done | Detected | Carrier state |
Iannitto et al.61 | 60 | F | CLL | Neg | Pos | Pos | Detected | Alemtuzumab | 4 weeks | Pos | Neg | Pos | Detected | Serologic resolution |
Berger et al.62 | 75 | M | PCKD | Neg | Pos | Pos | Negative | Renal transplant | 5 yrs | Pos | Neg | Pos | Detected | N.S. b |
Kempinska63 | 47 | M | AML | Neg | Pos | Pos | Not done | Bone Marrow Transp | 17 months | Pos | Neg | Pos | Detected | Chronic hepatitis |
Gwak et al.37 | 66 | F | Rheum Arthritis | Neg | Pos | Not done | Negative | Methotrexate | 7 yrs | Pos | Neg | Neg | Detected | Fulminant liver failure, death |
Awerkiew et al.64 | 36 | M | NHL | Neg | Pos | Neg | Not done | Cytotoxic Chemo | 5 yrs | Pos | Pos | Neg | Detected | Death |
Giudice et al.65 | 13 | M | AML | Neg | Pos | Pos | Detected | Bone Marrow Transp | 6 mos | Pos | Neg | Neg | Detected | Chronic hepatitis |
Oshima et al.66 | 42 | F | ALL | Neg | Pos | Pos | Not done | Bone Marrow Transp | 23 mos | Pos | Neg | Pos | Detected | Serologic resolution |
Published case series not included because they do not present individual-level clinical data57: Seth et al.,57 Onozawa et al.,58 Uhm et al.54
N.S., not specified
Reverse seroconversion occurred prior to chemotherapy
CML, chronic myelogenous leukemia; SAA, severe aplastic anemia; AML, acute myelogenous leukemia; ALL, acute lymphoblastic leukemia; NHL, non-Hodgkins lymphoma; PCKD, polycystic kidney disease